Reid Tirissa J, Saeed Saqib, McCoy Shiranda, Osewa Adebola A, Persaud Amrita, Ahmed Leaque
Department of Surgery, Harlem Hospital, New York, New York; Department of Medicine, Columbia University, College of Physicians and Surgeons, New York, New York.
Department of Surgery, Harlem Hospital, New York, New York.
Surg Obes Relat Dis. 2014 Sep-Oct;10(5):808-13. doi: 10.1016/j.soard.2014.02.048. Epub 2014 Jun 6.
Obesity is associated with albuminuria and impaired renal function. We previously reported on 38 nondiabetics with improved albuminuria after Roux-en-Y gastric bypass (RYGB).
Our objectives were to evaluate changes in renal function, urinary albumin-to-creatinine ratio (UACR), and glomerular filtration rate (GFR) in a larger cohort of patients with normal or mildly impaired renal function, undergoing RYGB or sleeve gastrectomy at 1 year postop. This was a retrospective study. Inclusions: patients with preoperative and 1 year postoperative serum and urine albumin and creatinine and weight (kg).
preop chronic kidney disease (CKD)≥Stage 3 or macroalbuminuria (UACR≥300 mg/g).
changes in UACR and estimated GFR (eGFR) at 1 year. The setting was in a public hospital in New York City, 2004-2011.
158 patients met inclusion criteria; 91.8% female; mean age 40.8 years; 84.2% white Hispanic, 14.6 % black. Hypertension was present in 43.0%, diabetes mellitus in 28.5%. UACR was 21.5±3.2 mg/g, decreasing to 10.2±1.2 mg/g at 1 year (P<.0001). Microalbuminuria was present in 22/158 patients (14%) preop, resolving in 82% at 1 year; pre- versus 1 year postop eGFR, 97.5±2.2 versus 87.1±2.0 mL/min (P<.0001). Hyperfiltration was present in 8.2% preop, decreasing to 4.4% 1 year postop.
In this mainly female minority population, UACR decreased within the normal range, while eGFR decreased from normal to the range for Stage 2 CKD at 1 year postop. Microalbuminuria resolved in most affected and hyperfiltration resolved in nearly half of those affected. This study is limited by its retrospective nature. Prospective studies should be performed.
肥胖与蛋白尿和肾功能受损有关。我们之前报道过38例非糖尿病患者在接受Roux-en-Y胃旁路术(RYGB)后蛋白尿得到改善。
我们的目标是评估一大群肾功能正常或轻度受损、在术后1年接受RYGB或袖状胃切除术的患者的肾功能、尿白蛋白与肌酐比值(UACR)和肾小球滤过率(GFR)的变化。这是一项回顾性研究。纳入标准:有术前及术后1年血清和尿液白蛋白、肌酐及体重(千克)数据的患者。
术前慢性肾脏病(CKD)≥3期或大量蛋白尿(UACR≥300mg/g)。
术后1年UACR和估算肾小球滤过率(eGFR)的变化。研究地点为纽约市的一家公立医院,时间为2004年至2011年。
158例患者符合纳入标准;91.8%为女性;平均年龄40.8岁;84.2%为西班牙裔白人,14.6%为黑人。43.0%的患者患有高血压,28.5%的患者患有糖尿病。UACR为21.5±3.2mg/g,术后1年降至10.2±1.2mg/g(P<0.0001)。术前22/158例患者(14%)存在微量白蛋白尿,术后1年82%得到缓解;术前与术后1年的eGFR分别为97.5±2.2与87.1±2.0ml/min(P<0.0001)。术前8.2%的患者存在超滤,术后1年降至4.4%。
在这个以女性少数族裔为主的人群中,UACR在正常范围内下降,而eGFR在术后1年从正常降至2期CKD范围。大多数受影响的微量白蛋白尿患者得到缓解,近一半受影响的超滤患者得到缓解。本研究受其回顾性性质的限制。应开展前瞻性研究。